A recent study evaluated Ac-Lys0(800CW)Tyr3-ocreotate (800CW-TATE) (Table 1), targeting somatostatin receptor subtype 2 (SSTR2), as a potential tracer in fluorescence-guided surgery of meningiomas. Here, SSTR2 is linked to meningioma.